EU – Chemical Safety Report – CSR – REACH Authorisation decisions – Triton X-100 – Ortho-clinical-Use1 By Marcelo Antunes on October 29, 2019 CSR – REACH Authorisation decisions – Triton X-100 – Ortho-clinical-Use1 CSR – REACH Authorisation decisions – Triton X-100 – Ortho-clinical-Use2 Published in Europe and Regulation on Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) Authorisation and Restriction of Chemicals (REACH) Marcelo Antunes More from EuropeMore posts in Europe »EU – Guidance – Clinical evaluation assessment report templateEU – Checklist for EN 17466 & Validation (Instructions for use for reusable & re-sterilisable medical devices)EU – Team NB position statement on the requirements for the EU MDR/IVDR Notified Body Partners under the Technical Cooperation Program on Exchange of Medical Device Quality Management System Regulation and ISO 13485 Audit Reports (TCP III)UK – MHRA – Medical Device “Certificates of Compliance” / “Attestation of Conformity” have no legal standing under MDREU – Availability and capacity of notified bodies to carry out conformity assessments for COVID-19 related medical devices and in vitro diagnostic medical devicesMore from Regulation on Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH)More posts in Regulation on Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) »EU – REACH Authorisation Decisions List
Be First to Comment